Qube Research & Technologies (QRT)’s Actuate Therapeutics ACTU Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACTU Stock Details ACTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.3K	Buy	+15,256	New	+$35.4K	﹤0.01%	3211

Other funds holding ACTU

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return

PVM

Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ADEF

ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ACTU Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Actuate Therapeutics (ACTU) in Q2 2026: 15,256 shares worth $23.3K. The stake represents ﹤0.01% of the portfolio and ranks #3211 among its holdings.

64 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

Qube Research & Technologies (QRT) held 15,256 shares of Actuate Therapeutics worth $23.3K as of Q2 2026.
Actuate Therapeutics was a new Qube Research & Technologies (QRT) position in Q2 2026.
Actuate Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3211 holding.
64 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.